UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 112

Sortiert nach

JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis

Rheumatology (Oxford, England), 2019-02, Vol.58 (Supplement_1), p.i43-i54

2019

Link zum Volltext

Verfügbarkeit prüfen

MicroRNAs in rheumatoid arthritis: From pathogenesis to clinical impact

Autoimmunity reviews, 2019-11, Vol.18 (11), p.102391, Article 102391

2019

Link zum Volltext

Verfügbarkeit prüfen

Methotrexate and interstitial lung disease: controversies and questions. A narrative review of the literature

Rheumatology (Oxford, England), 2019-11, Vol.58 (11), p.1900-1906

2019

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases

Annual review of medicine, 2016-01, Vol.67 (1), p.337-353

2016

Link zum Volltext

Verfügbarkeit prüfen

The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions

Journal of allergy and clinical immunology, 2021-10, Vol.148 (4), p.941-952

2021

Link zum Volltext

Verfügbarkeit prüfen

Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment

Frontiers in medicine, 2019-10, Vol.6, p.238-238

2019

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular Risk in Rheumatoid Arthritis and Mechanistic Links: From Pathophysiology to Treatment

Current vascular pharmacology, 2020-01, Vol.18 (5), p.431

2020

Link zum Volltext

Verfügbarkeit prüfen

Ocular manifestations of IgG4-related disease in children. More common than anticipated? Review of the literature and case report

Clinical rheumatology, 2018-06, Vol.37 (6), p.1721-1727

2018

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment

World journal of gastroenterology : WJG, 2019-05, Vol.25 (18), p.2162-2176

2019

Link zum Volltext

Verfügbarkeit prüfen

Treatment strategies in axial spondyloarthritis: what, when and how?

Rheumatology (Oxford, England), 2020-10, Vol.59 (Suppl4), p.iv79-iv89

2020

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis and targeted synthetic or biologic DMARDs, beyond tumor necrosis factor inhibitors

Therapeutic Advances in Musculoskeletal Disease, 2020, Vol.12, p.1759720X20930116-1759720X20930116

2020

Link zum Volltext

Verfügbarkeit prüfen

Depression and anxiety in an early rheumatoid arthritis inception cohort. associations with demographic, socioeconomic and disease features

Rheumatic & musculoskeletal diseases open, 2020-10, Vol.6 (3), p.e001376

2020

Link zum Volltext

Verfügbarkeit prüfen

Type-I interferon pathway and DNA damage accumulation in peripheral blood of patients with psoriatic arthritis

Frontiers in immunology, 2023-12, Vol.14, p.1274060-1274060

2023

Link zum Volltext

Verfügbarkeit prüfen

Overview of IgG4-related aortitis and periaortitis. A decade since their first description

Autoimmunity reviews, 2020-12, Vol.19 (12), p.102694, Article 102694

2020

Link zum Volltext

Verfügbarkeit prüfen

Depression in spondyloarthritis: can we kill two birds with one stone?

Rheumatology (Oxford, England), 2023-06, Vol.62 (6), p.2035-2036

2023

Link zum Volltext

Verfügbarkeit prüfen

Hidradenitis suppurativa: infection, autoimmunity, or both?

Therapeutic Advances in Musculoskeletal Disease, 2019, Vol.11, p.1759720X19895488-1759720X19895488

2019

Link zum Volltext

Verfügbarkeit prüfen

Comorbidities in Psoriatic Arthritis: A Narrative Review

Clinical therapeutics, 2023-02, Vol.45 (2), p.177-189

2023

Link zum Volltext

Verfügbarkeit prüfen

Impaired clearance of early apoptotic cells mediated by inhibitory IgG antibodies in patients with primary Sjögren's syndrome

PloS one, 2014-11, Vol.9 (11), p.e112100-e112100

2014

Link zum Volltext

Verfügbarkeit prüfen

Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus

Therapeutic advances in musculoskeletal disease, 2020, Vol.12, p.1759720X20976975-1759720X20976975

2020

Link zum Volltext

Verfügbarkeit prüfen

When rheumatology and infectious disease come together

Therapeutic advances in musculoskeletal disease, 2019, Vol.11, p.1759720X19868901-1759720X19868901

2019

Link zum Volltext

Verfügbarkeit prüfen

JAK inhibitors, cardiovascular and thromboembolic events: what we know and what we would like to know

Clinical rheumatology, 2023-03, Vol.42 (3), p.959-962

2023

Link zum Volltext

Verfügbarkeit prüfen

Late-Onset Psoriatic Arthritis: Are There Any Distinct Characteristics? A Retrospective Cohort Data Analysis

Life (Basel, Switzerland), 2023-03, Vol.13 (3), p.792

2023

Link zum Volltext

Verfügbarkeit prüfen

Normal C-reactive protein in active psoriatic arthritis: results from real-world clinical practice

Therapeutic advances in musculoskeletal disease, 2022, Vol.14, p.1759720-1759720X221122417

2022

Link zum Volltext

Verfügbarkeit prüfen

Hypogammaglobulinemia after rituximab for rheumatoid arthritis is not rare and is related with good response: 13 years real-life experience

Rheumatology (Oxford, England), 2021-05, Vol.60 (5), p.2375-2382

2021

Link zum Volltext

Verfügbarkeit prüfen

Systematic literature review informing the 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases

RMD Open, 2022-11, Vol.8 (2), p.e002726

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(98)

Publikationsform

Sprache

Englisch
(112)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(96)
Life Sciences & Biomedicine
(94)
Rheumatology
(68)
Humans
(61)
Rheumatoid Arthritis
(25)
Female
(22)
Male
(22)
Medicine
(21)
Middle Aged
(20)
Medicine & Public Health
(19)
Adult
(17)
Arthritis
(17)
Immunology
(15)
Aged
(14)
Psoriatic Arthritis
(14)
Patients
(11)
Rheumatic Diseases
(11)
Risk Factors
(11)
Arthritis, Rheumatoid - Drug Therapy
(10)
Covid-19
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis

MicroRNAs in rheumatoid arthritis: From pathogenesis to clinical impact

Methotrexate and interstitial lung disease: controversies and questions. A narrative review of the literature

Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases

The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions

Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment

Cardiovascular Risk in Rheumatoid Arthritis and Mechanistic Links: From Pathophysiology to Treatment

Ocular manifestations of IgG4-related disease in children. More common than anticipated? Review of the literature and case report

Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment

Treatment strategies in axial spondyloarthritis: what, when and how?

Tuberculosis and targeted synthetic or biologic DMARDs, beyond tumor necrosis factor inhibitors

Depression and anxiety in an early rheumatoid arthritis inception cohort. associations with demographic, socioeconomic and disease features

Type-I interferon pathway and DNA damage accumulation in peripheral blood of patients with psoriatic arthritis

Overview of IgG4-related aortitis and periaortitis. A decade since their first description

Depression in spondyloarthritis: can we kill two birds with one stone?

Hidradenitis suppurativa: infection, autoimmunity, or both?

Comorbidities in Psoriatic Arthritis: A Narrative Review

Impaired clearance of early apoptotic cells mediated by inhibitory IgG antibodies in patients with primary Sjögren's syndrome

Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus

When rheumatology and infectious disease come together

JAK inhibitors, cardiovascular and thromboembolic events: what we know and what we would like to know

Late-Onset Psoriatic Arthritis: Are There Any Distinct Characteristics? A Retrospective Cohort Data Analysis

Normal C-reactive protein in active psoriatic arthritis: results from real-world clinical practice

Hypogammaglobulinemia after rituximab for rheumatoid arthritis is not rare and is related with good response: 13 years real-life experience

Systematic literature review informing the 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases

Suchergebnisse filtern